PTCT
Ptc Therapeutics·NASDAQ
--
--(--)
--
--(--)
8.12 / 10
Outperform
Sentiment and fund‑flow scores exceed 8, with excellent inflow ratios across all investor sizes. Analyst consensus is 75% bullish (25% Strong Buy, 50% Buy). Despite insider selling, strong analyst win rates and positive capital flows reinforce a bullish stance.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
25%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-20
InstitutionWells Fargo
Times predicted2
Historical Win Rate50.0%
What is the analyst consensus for PTCT?
- PTCT holds a Bullish analyst rating, with 50% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 8.12/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
